000			01559 a2200433 4500
005			20250516203322.0
264		0	_c20141209
008			201412s 0 0 eng d
022			_a1873-2623
024	7		_a10.1016/j.transproceed.2013.11.121 _2doi
040			_aNLM _beng _cNLM
100	1		_aWanitchanont, A
245	0	0	_aEffects of atorvastatin on the pharmacokinetics of everolimus among kidney transplant recipients. _h[electronic resource]
260			_bTransplantation proceedings _c2014
300			_a418-21 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aArea Under Curve
650	0	4	_aAtorvastatin
650	0	4	_aCross-Over Studies
650	0	4	_aEverolimus
650	0	4	_aHeptanoic Acids _xadverse effects
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects
650	0	4	_aImmunosuppressive Agents _xpharmacokinetics
650	0	4	_aKidney Transplantation
650	0	4	_aMiddle Aged
650	0	4	_aProspective Studies
650	0	4	_aPyrroles _xadverse effects
650	0	4	_aSirolimus _xadverse effects
700	1		_aSomparn, P
700	1		_aVadcharavivad, S
700	1		_aChancharoenthana, W
700	1		_aTownamchai, N
700	1		_aPraditpornsilpa, K
700	1		_aAvihingsanon, Y
773	0		_tTransplantation proceedings _gvol. 46 _gno. 2 _gp. 418-21
856	4	0	_uhttps://doi.org/10.1016/j.transproceed.2013.11.121 _zAvailable from publisher's website
999			_c23664246 _d23664246